Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

AMRI to close former Euticals site

by Rick Mullin
September 5, 2016 | A version of this story appeared in Volume 94, Issue 35

Albany Molecular Research Inc. (AMRI) has embarked on a restructuring in the wake of its May acquisition of the Italian pharmaceutical chemicals maker Euticals for $358 million. AMRI says it will close a Euticals facility and lay off an undisclosed number of workers in the U.S. and Europe by the end of the year. AMRI expects to incur a onetime charge of up to $7.3 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.